4//SEC Filing
IGI LABORATORIES, INC 4
Accession 0001181431-14-030520
CIK 0000352998operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 3:54 PM ET
Size
15.6 KB
Accession
0001181431-14-030520
Insider Transaction Report
Form 4
LIFE SCIENCES OPPORTUNITIES FUND II LP
Director10% Owner
Transactions
- Sale
Common Stock
2014-08-27$6.20/sh−455,257$2,822,593→ 2,102,053 total - Sale
Common Stock
2014-08-27$6.20/sh−2,544,743$15,777,407→ 11,749,808 total
GALE JAMES C
Director10% Owner
Transactions
- Sale
Common Stock
2014-08-27$6.20/sh−455,257$2,822,593→ 2,102,053 total - Sale
Common Stock
2014-08-27$6.20/sh−2,544,743$15,777,407→ 11,749,808 total
LOF PARTNERS LLC
10% Owner
Transactions
- Sale
Common Stock
2014-08-27$6.20/sh−2,544,743$15,777,407→ 11,749,808 total - Sale
Common Stock
2014-08-27$6.20/sh−455,257$2,822,593→ 2,102,053 total
LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP
Director10% Owner
Transactions
- Sale
Common Stock
2014-08-27$6.20/sh−2,544,743$15,777,407→ 11,749,808 total - Sale
Common Stock
2014-08-27$6.20/sh−455,257$2,822,593→ 2,102,053 total
SANDERS DON A
Other
Transactions
- Sale
Common Stock
2014-08-27$6.20/sh−455,257$2,822,593→ 2,102,053 total - Sale
Common Stock
2014-08-27$6.20/sh−2,544,743$15,777,407→ 11,749,808 total
MORRIS BENJAMIN T
10% Owner
Transactions
- Sale
Common Stock
2014-08-27$6.20/sh−455,257$2,822,593→ 2,102,053 total - Sale
Common Stock
2014-08-27$6.20/sh−2,544,743$15,777,407→ 11,749,808 total
Footnotes (2)
- [F1]These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW"), the controlling member of the General Partner, and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
- [F2]These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, the controlling member of the General Partner, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
Documents
Issuer
IGI LABORATORIES, INC
CIK 0000352998
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000352998
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 3:54 PM ET
- Size
- 15.6 KB